HR 1672 · 119th Congress
Maintaining Investments in New Innovation Act
This bill makes it easier for pharmaceutical companies to develop and profit from cutting-edge genetic medicines by extending the period during which the government can't negotiate lower prices for these drugs. Right now, when a new drug comes to market, the government has a 7-year window before it can use its purch…
- Sponsor
- Davis, Donald G. (D-North Carolina)
- Introduced
- 2025-02-27
- Policy area
- Health
- Latest action
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Digging through Congress... 🔍